The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Hepatocellular carcinoma: a review
Open accessAbstract
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. In the United States, HCC is the ninth leading cause of cancer deaths. Despite advances in prevention techniques, screening, and new technologies in both diagnosis and treatment, incidence and mortality continue to rise. Cirrhosis remains the most important risk factor for the development of HCC regardless of etiology. Hepatitis B and C are independent risk factors for the development of cirrhosis. Alcohol consumption remains an important additional risk factor in the United States as alcohol abuse is five times higher than hepatitis C. Diagnosis is confirmed without pathologic confirmation. Screening includes both radiologic tests, such as ultrasound, computerized tomography, and magnetic resonance imaging, and serological markers such as α-fetoprotein at 6-month intervals. Multiple treatment modalities exist; however, only orthotopic liver transplantation (OLT) or surgical resection is curative. OLT is available for patients who meet or are downstaged into the Milan or University of San Francisco criteria. Additional treatment modalities include transarterial chemoembolization, radiofrequency ablation, microwave ablation, percutaneous ethanol injection, cryoablation, radiation therapy, systemic chemotherapy, and molecularly targeted therapies. Selection of a treatment modality is based on tumor size, location, extrahepatic spread, and underlying liver function. HCC is an aggressive cancer that occurs in the setting of cirrhosis and commonly presents in advanced stages. HCC can be prevented if there are appropriate measures taken, including hepatitis B virus vaccination, universal screening of blood products, use of safe injection practices, treatment and education of alcoholics and intravenous drug users, and initiation of antiviral therapy. Continued improvement in both surgical and nonsurgical approaches has demonstrated significant benefits in overall survival. While OLT remains the only curative surgical procedure, the shortage of available organs precludes this therapy for many patients with HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
International Agency for Research on Cancer (IARC)
(2018) · The Grants Register 2018 · doi:10.1007/978-1-349-94186-5_629 · Cited by 2,801
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Yao, F. Y., Ferrell, L., Bass, N. M., Watson, J. J., Bacchetti, P., Venook, A., Ascher, N. L., & Roberts, J. P. (2001) · Hepatology · doi:10.1053/jhep.2001.24563 · Cited by 2,262
Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012) · Vaccine · doi:10.1016/j.vaccine.2011.12.116 · Cited by 1,843
Genetic organization and diversity of the hepatitis C virus.
Choo, Q. L., Richman, K. H., Han, J. H., Berger, K., Lee, C., Dong, C., Gallegos, C., Coit, D., Medina-Selby, R., & Barr, P. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.6.2451 · Cited by 1,716
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Imamura, H., Matsuyama, Y., Tanaka, E., Ohkubo, T., Hasegawa, K., Miyagawa, S., Sugawara, Y., Minagawa, M., Takayama, T., Kawasaki, S., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00360-4 · Cited by 1,589
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
Monographs on the Evaluation of Carcinogenic Risks to Humans
(1991) · Analytica Chimica Acta · doi:10.1016/s0003-2670(00)84695-4 · Cited by 1,303
Global burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment
Liu, Y., & Wu, F. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901388 · Cited by 1,224
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Forner, A., Reig, M. E., Rodriguez de Lope, C., & Bruix, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247133 · Cited by 1,110
Livraghi, T., Meloni, F., Di Stasi, M., Rolle, E., Solbiati, L., Tinelli, C., & Rossi, S. (2008) · Hepatology · doi:10.1002/hep.21933 · Cited by 1,103
Tobacco smoking and cancer: A meta‐analysis
Gandini, S., Botteri, E., Iodice, S., Boniol, M., Lowenfels, A. B., Maisonneuve, P., & Boyle, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23033 · Cited by 971
The natural history of chronic hepatitis B virus infection #
McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.22898 · Cited by 876
Lencioni, R., Cioni, D., Crocetti, L., Franchini, C., Pina, C. D., Lera, J., & Bartolozzi, C. (2005) · Radiology · doi:10.1148/radiol.2343040350 · Cited by 867
Lipid Metabolism and Liver Inflammation. II. Fatty liver disease and fatty acid oxidation
Reddy, J. K., & Sambasiva Rao, M. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00521.2005 · Cited by 860
Poon, R. T.-P., Fan, S. T., Lo, C. M., Liu, C. L., & Wong, J. (2002) · Annals of Surgery · doi:10.1097/00000658-200203000-00009 · Cited by 844
Morgan, R. L., Baack, B., Smith, B. D., Yartel, A., Pitasi, M., & Falck-Ytter, Y. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-5-201303050-00005 · Cited by 829
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Bruix, J., Raoul, J.-L., Sherman, M., Mazzaferro, V., Bolondi, L., Craxi, A., Galle, P. R., Santoro, A., Beaugrand, M., Sangiovanni, A., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.06.014 · Cited by 822
Takayasu, K., Arii, S., Ikai, I., Omata, M., Okita, K., Ichida, T., Matsuyama, Y., Nakanuma, Y., Kojiro, M., Makuuchi, M., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.021 · Cited by 810
Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update
Vivarelli, M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i42.7316 · Cited by 799
Management of hepatitis B: 2000—Summary of a workshop
Lok, A. S., Heathcote, E. J., & Hoofnagle, J. H. (2001) · Gastroenterology · doi:10.1053/gast.2001.24839 · Cited by 776
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein, S. T., Zhou, F., Hadler, S. C., Bell, B. P., Mast, E. E., & Margolis, H. S. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi206 · Cited by 743
Trevisani, F., D'Intino, P. E., Morselli-Labate, A. M., Mazzella, G., Accogli, E., Caraceni, P., Domenicali, M., De Notariis, S., Roda, E., & Bernardi, M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00053-2 · Cited by 731
Hepatectomy for Hepatocellular Carcinoma: Toward Zero Hospital Deaths
Fan, S.-T., Lo, C.-M., Liu, C.-L., Lam, C.-M., Yuen, W.-K., Yeung, C., & Wong, J. (1999) · Annals of Surgery · doi:10.1097/00000658-199903000-00004 · Cited by 728
Wong, R. J., Cheung, R., & Ahmed, A. (2014) · Hepatology · doi:10.1002/hep.26986 · Cited by 723
Hosaka, T., Suzuki, F., Kobayashi, M., Seko, Y., Kawamura, Y., Sezaki, H., Akuta, N., Suzuki, Y., Saitoh, S., Arase, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26180 · Cited by 710
Simplified Staging for Hepatocellular Carcinoma
Vauthey, J. N., Lauwers, G. Y., Esnaola, N. F., Do, K.-A., Belghiti, J., Mirza, N., Curley, S. A., Ellis, L. M., Regimbeau, J.-M., Rashid, A., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1527 · Cited by 700
Preoperative Portal Vein Embolization for Major Liver Resection: A Meta-Analysis
Abulkhir, A., Limongelli, P., Healey, A. J., Damrah, O., Tait, P., Jackson, J., Habib, N., & Jiao, L. R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815f6e5b · Cited by 673
Sangro, B., Carpanese, L., Cianni, R., Golfieri, R., Gasparini, D., Ezziddin, S., Paprottka, P. M., Fiore, F., Van Buskirk, M., Bilbao, J. I., et al. (2011) · Hepatology · doi:10.1002/hep.24451 · Cited by 652
Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M., & Sherman, M. (2001) · Gut · doi:10.1136/gut.48.2.251 · Cited by 643
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Kulik, L. M., Carr, B. I., Mulcahy, M. F., Lewandowski, R. J., Atassi, B., Ryu, R. K., Sato, K. T., Benson, A., Nemcek, A. A., Gates, V. L., et al. (2008) · Hepatology · doi:10.1002/hep.21980 · Cited by 620
A model to predict survival in patients with end-stage liver disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W. K., Therneau, T. M., D'Amico, G., Kosberg, C. L., Dickson, E. R., & Kim, W. R. (2001) · Gastroenterology · doi:10.1016/s0016-5085(08)80377-0 · Cited by 615
Mazzaferro, V., Bhoori, S., Sposito, C., Bongini, M., Langer, M., Miceli, R., & Mariani, L. (2011) · Liver Transplantation · doi:10.1002/lt.22365 · Cited by 593
Colli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., & Duca, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00467.x · Cited by 540
Raoul, J.-L., Sangro, B., Forner, A., Mazzaferro, V., Piscaglia, F., Bolondi, L., & Lencioni, R. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.07.006 · Cited by 537
Lee, Y. J., Lee, J. M., Lee, J. S., Lee, H. Y., Park, B. H., Kim, Y. H., Han, J. K., & Choi, B. I. (2015) · Radiology · doi:10.1148/radiol.14140690 · Cited by 526
Yao, F. Y., Kerlan, R. K., Hirose, R., Davern, T. J., Bass, N. M., Feng, S., Peters, M., Terrault, N., Freise, C. E., Ascher, N. L., et al. (2008) · Hepatology · doi:10.1002/hep.22412 · Cited by 513
Alifakioti, D., Daccord, C., Lachenal, Y., & Fitting, J.-W. (2014) · Respiration · doi:10.1159/000367814 · Cited by 495
Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies
Larsson, S. C., & Wolk, A. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603932 · Cited by 495
Torzilli, G. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.9.984 · Cited by 455
Wang, C., Wang, X., Gong, G., Ben, Q., Qiu, W., Chen, Y., Li, G., & Wang, L. (2012) · International Journal of Cancer · doi:10.1002/ijc.26165 · Cited by 449
Screening for hepatocellular carcinoma
Collier, J., & Sherman, M. (1998) · Hepatology · doi:10.1002/hep.510270140 · Cited by 425
Sangiovanni, A., Manini, M. A., Iavarone, M., Romeo, R., Forzenigo, L. V., Fraquelli, M., Massironi, S., Della Corte, C., Ronchi, G., Rumi, M. G., et al. (2010) · Gut · doi:10.1136/gut.2009.187286 · Cited by 408
Marrero, J. A., Su, G. L., Wei, W., Emick, D., Conjeevaram, H. S., Fontana, R. J., & Lok, A. S. (2003) · Hepatology · doi:10.1053/jhep.2003.50195 · Cited by 387
Verslype, C., Rosmorduc, O., & Rougier, P. (2012) · Annals of Oncology · doi:10.1093/annonc/mds225 · Cited by 365
Wald, C., Russo, M. W., Heimbach, J. K., Hussain, H. K., Pomfret, E. A., & Bruix, J. (2013) · Radiology · doi:10.1148/radiol.12121698 · Cited by 363
Sherman, M., Peltekian, K. M., & Lee, C. (1995) · Hepatology · doi:10.1002/hep.1840220210 · Cited by 357
Iavarone, M., Cabibbo, G., Piscaglia, F., Zavaglia, C., Grieco, A., Villa, E., Cammà, C., & Colombo, M. (2010) · Hepatology · doi:10.1002/hep.24644 · Cited by 352
Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial
Di Bisceglie, A. M., Sterling, R. K., Chung, R. T., Everhart, J. E., Dienstag, J. L., Bonkovsky, H. L., Wright, E. C., Everson, G. T., Lindsay, K. L., Lok, A. S. F., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.019 · Cited by 350
Population-based risk factors and resource utilization for HCC: US perspective
Sanyal, A., Poklepovic, A., Moyneur, E., & Barghout, V. (2010) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.506375 · Cited by 312
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
Yao, F. Y., Hirose, R., LaBerge, J. M., Davern, T. J., Bass, N. M., Kerlan, R. K., Merriman, R., Feng, S., Freise, C. E., Ascher, N. L., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20526 · Cited by 288
Raoul, J., Guyader, D., Bretagne, J., Heautot, J., Duvauferrier, R., Bourguet, P., Bekhechi, D., Deugnier, Y. M., & Gosselin, M. (1997) · Hepatology · doi:10.1002/hep.510260511 · Cited by 286
DuBay, D., Sandroussi, C., Sandhu, L., Cleary, S., Guba, M., Cattral, M. S., McGilvray, I., Ghanekar, A., Selzner, M., Greig, P. D., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e31820508f1 · Cited by 286
Cherqui, D., Laurent, A., Mocellin, N., Tayar, C., Luciani, A., Van Nhieu, J. T., Decaens, T., Hurtova, M., Memeo, R., Mallat, A., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bd582b · Cited by 278
Chen, G., Lin, W., Shen, F., Iloeje, U. H., London, W. T., & Evans, A. A. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00647.x · Cited by 275
Strategies for the management of hepatocellular carcinoma
Schwartz, M., Roayaie, S., & Konstadoulakis, M. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0844 · Cited by 261
Riaz, A., Kulik, L., Lewandowski, R. J., Ryu, R. K., Giakoumis Spear, G., Mulcahy, M. F., Abecassis, M., Baker, T., Gates, V., Nayar, R., et al. (2009) · Hepatology · doi:10.1002/hep.22747 · Cited by 260
Teh, S. H., Christein, J., Donohue, J., Que, F., Kendrick, M., Farnell, M., Cha, S., Kamath, P., Kim, R., & Nagorney, D. M. (2005) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2005.09.008 · Cited by 255
Puoti, M., Bruno, R., Soriano, V., Donato, F., Gaeta, G. B., Quinzan, G. P., Precone, D., Gelatti, U., Asensi, V., & Vaccher, E. (2004) · AIDS · doi:10.1097/00002030-200411190-00009 · Cited by 249
Transcatheter Intraarterial Therapies: Rationale and Overview
Lewandowski, R. J., Geschwind, J.-F., Liapi, E., & Salem, R. (2011) · Radiology · doi:10.1148/radiol.11081489 · Cited by 248
Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan
Chiang, C.-J., Yang, Y.-W., You, S.-L., Lai, M.-S., & Chen, C.-J. (2013) · JAMA · doi:10.1001/jama.2013.276701 · Cited by 247
Familial Risk of Hepatocellular Carcinoma Among Chronic Hepatitis B Carriers and Their Relatives
Yu, M.-W. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.14.1159 · Cited by 235
Toso, C., Trotter, J., Wei, A., Bigam, D. L., Shah, S., Lancaster, J., Grant, D. R., Greig, P. D., Shapiro, A. M. J., & Kneteman, N. M. (2008) · Liver Transplantation · doi:10.1002/lt.21484 · Cited by 230
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
Turati, F., Galeone, C., Rota, M., Pelucchi, C., Negri, E., Bagnardi, V., Corrao, G., Boffetta, P., & La Vecchia, C. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu020 · Cited by 229
Singal, A. G., Nehra, M., Adams-Huet, B., Yopp, A. C., Tiro, J. A., Marrero, J. A., Lok, A. S., & Lee, W. M. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.449 · Cited by 225
Current management of hepatocellular carcinoma.
Crissien, A. M., & Frenette, C. T. (2014) · Europe PMC (PubMed Central) · Cited by 215
Dempsey, D. T. (2006) · Yearbook of Gastroenterology · doi:10.1016/s0739-5930(08)70399-4 · Cited by 201
Gambarin-Gelwan, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)00883-2 · Cited by 184
Bertot, L. C., Sato, M., Tateishi, R., Yoshida, H., & Koike, K. (2011) · European Radiology · doi:10.1007/s00330-011-2222-3 · Cited by 170
Current management of hepatocellular carcinoma
Tabrizian, P. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10223 · Cited by 168
Lin, O. S., Keeffe, E. B., Sanders, G. D., & Owens, D. K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01963.x · Cited by 168
AASLD PRACTICE GUIDELINE Management of Hepatocellular Carcinoma: An Update
Bruix, J., & Sherman, M. (2010) · Cited by 166
Hepatocellular carcinoma - United States, 2001-2006.
O’Connor, S., Ward, J. W., Watson, M. J., Momin, B. R., & Richardson, L. C. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 165
Reduced Aflatoxin Exposure Presages Decline in Liver Cancer Mortality in an Endemic Region of China
Chen, J.-G., Egner, P. A., Ng, D., Jacobson, L. P., Muñoz, A., Zhu, Y.-R., Qian, G.-S., Wu, F., Yuan, J.-M., Groopman, J. D., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0168 · Cited by 164
Surgical treatment of hepatocellular carcinoma
Belghiti, J., & Kianmanesh, R. (2005) · HPB · doi:10.1080/13651820410024067 · Cited by 161
Sorafenib therapy in advanced hepatocellular carcinoma: the SHARP trial
Rimassa, L., & Santoro, A. (2009) · Expert Review of Anticancer Therapy · doi:10.1586/era.09.41 · Cited by 159
Nguyen, M. H., Garcia, R. T., Simpson, P. W., Wright, T. L., & Keeffe, E. B. (2002) · Hepatology · doi:10.1053/jhep.2002.34744 · Cited by 159
Mechanisms of Synergy Between Alcohol and Hepatitis C Virus
Singal, A. K., & Anand, B. S. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3180381584 · Cited by 152
Iron and hepatocellular carcinoma
Deugnier, Y., & Turlin, B. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02430.x · Cited by 147
An overview about hepatitis C: A devastating virus
Bostan, N., & Mahmood, T. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903357455 · Cited by 145
van Meer, S., de Man, R. A., Coenraad, M. J., Sprengers, D., van Nieuwkerk, K. M. J., Klümpen, H., Jansen, P. L. M., IJzermans, J. N. M., van Oijen, M. G. H., Siersema, P. D., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.012 · Cited by 139
Trevisani, F., Santi, V., Gramenzi, A., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G., Farinati, F., Zoli, M., Borzio, F., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01395.x · Cited by 131
Oral contraception and the risk of hepatocellular carcinoma
Maheshwari, S., Sarraj, A., Kramer, J., & El‐Serag, H. B. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.015 · Cited by 124
Hepatocellular carcinoma - United States, 2001-2006.
(2010) · PubMed · Cited by 118
Hagiwara, S., Kudo, M., Nagai, T., Inoue, T., Ueshima, K., Nishida, N., Watanabe, T., & Sakurai, T. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.145 · Cited by 115
Khien, V. V., Mao, H. V., Chinh, T.-T., Ha, P. T., Bang, M. H., Lac, B. V., Hop, T. V., Tuan, N. A., Don, L. V., Taketa, K., et al. (2001) · The International Journal of Biological Markers · doi:10.1177/172460080101600204 · Cited by 113
Updates in the management of hepatocellular carcinoma.
Wong, R. J., & Frenette, C. T. (2011) · PubMed · Cited by 110
Palavecino, M. E., Chun, Y. S., Madoff, D. C., et al. (2009) · Surgery · doi:10.1016/j.surg.2008.10.009 · Cited by 110
Hepatocellular carcinoma: natural history, current management, and emerging tools
Haas-Kogan, D. A., & Tinkle, C. L. (2012) · Biologics · doi:10.2147/btt.s23907 · Cited by 106
Roayaie, S., Ben‐Haim, M., Emre, S., et al. (2000) · Annals of Surgical Oncology · doi:10.1007/s10434-000-0764-8 · Cited by 106
A cohort study of serum testosterone and hepatocellular carcinoma in Shanghai, China
Yuan, J., Ross, R. K., Stanczyk, F. Z., Govindarajan, S., Gao, Y., Henderson, B. E., & Yu, M. C. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630405 · Cited by 101
Balkau, B., Kahn, H. S., Courbon, D., Eschwège, É., & Ducimetière, P. (2001) · Diabetes Care · doi:10.2337/diacare.24.5.843 · Cited by 101
Singhal, A., Jayaraman, M., Dhanasekaran, D. N., & Kohli, V. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.05.005 · Cited by 100
Ko, C. W., Siddaiah, N. B., Berger, J., Gish, R. G., Brandhagen, D. J., Sterling, R. K., Cotler, S. J., Fontana, R. J., McCashland, T. M., Han, S. H. B., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01596.x · Cited by 99
Surgical Outcomes for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Wakai, T., Shirai, Y., Sakata, J., Korita, P. V., Ajioka, Y., & Hatakeyama, K. (2011) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-011-1540-8 · Cited by 91
Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts.
Moore, M. A., Park, C. B., & Tsuda, H. (1998) · PubMed · Cited by 86
White, D. L., Tavakoli-Tabasi, S., Kuzniarek, J., Pascua, R., Ramsey, D. J., & El‐Serag, H. B. (2011) · Hepatology · doi:10.1002/hep.24618 · Cited by 85
Effect of age on the etiologic role of the hepatitis B virus in hepatocellular carcinoma in blacks
Kew, M. C., & Macerollo, P. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90434-9 · Cited by 73
Tokushige, K., Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., & Shiratori, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0237-1 · Cited by 72
Alcohol consumption and the risk of cirrhosis
Batey, R. G., Burns, T., Benson, R. J., & Byth, K. (1992) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb139846.x · Cited by 70
Liver resection for HCC with cirrhosis: Surgical perspectives out of EASL/AASLD guidelines
Capussotti, L., Ferrero, A., Viganò, L., Polastri, R., & Tabone, M. (2007) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2007.06.005 · Cited by 64
Wu, Q., Huang, H., Sun, X., Pan, M., He, Y., Tan, S., Zeng, Y., Li, L., Deng, G., Yan, Z., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.043 · Cited by 60
Management of Hepatocellular Carcinoma: Current Status and Future Directions
Au, J. S., & Frenette, C. T. (2015) · Gut and Liver · doi:10.5009/gnl15022 · Cited by 59
Trends in European liver death rates: implications for alcohol policy
Jewell, J. M., & Sheron, N. (2010) · Clinical Medicine · doi:10.7861/clinmedicine.10-3-259 · Cited by 51
Interactions Between Alcohol and Hepatitis Viruses in the Liver
Bréchot, C., Nalpas, B., & Feitelson, M. A. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30269-5 · Cited by 48
Management of hepatocellular carcinoma: Enlightening the gray zones
Mancuso, A. (2013) · World Journal of Hepatology · doi:10.4254/wjh.v5.i6.302 · Cited by 46
Gao, C., Fang, L., Zhao, H.-C., Li, J., & Yao, S. (2013) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(13)60060-0 · Cited by 43
Management of Hepatocellular Carcinoma
Asham, E. H., Kaseb, A. O., & Ghobrial, R. M. (2013) · Surgical Clinics of North America · doi:10.1016/j.suc.2013.08.008 · Cited by 41
Self-citationYao, F. Y. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-947295 · Cited by 37
Epidemiology of Hepatocellular Carcinoma
White, D. L., Firozi, A., & El‐Serag, H. B. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-376-3_1 · Cited by 34
Monsour, H., Asham, E. H., McFadden, R., Victor, D. W., Muthuswamy, B., & Zaheer, I. (2013) · Translational Cancer Research · doi:10.21037/1864 · Cited by 14
Self-citationHepatocellular Carcinoma: Prevention and Therapy
Sohal, D. P. S., & Sun, W. (2011) · Current Oncology Reports · doi:10.1007/s11912-011-0165-0 · Cited by 12
Cited by
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Kubes, P., & Jenne, C. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052415 · Cited by 923
Garin, E., Tselikas, L., Guiu, B., Chalaye, J., Edeline, J., de Baere, T., Assenat, E., Tacher, V., Robert, C., Terroir-Cassou-Mounat, M., et al. (2021) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30290-9 · Cited by 630
Xu, J., Shen, J., Gu, S., Zhang, Y., Wu, L., Wu, J., Shao, G., Zhang, Y., Xu, L., Yin, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2571 · Cited by 565
Ricke, J., Klümpen, H. J., Amthauer, H., Bargellini, I., Bartenstein, P., de Toni, E. N., Gasbarrini, A., Pech, M., Peck-Radosavljevic, M., Popovič, P., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.006 · Cited by 397
Metadata
- Authors
- Balogh, J., Victor, D., Asham, E. H., Burroughs, S. G., Boktour, M., Saharia, A., Li, X., Ghobrial, M., & Monsour, H.
- Venue
- Journal of Hepatocellular Carcinoma
- Publisher
- Informa UK Limited
- Published
- 2016-10
- Volume
- Volume 3
- Pages
- 41-53
- ISSN
- 2253-5969 (ISSN-L)
- OpenAlex
- W2529646902
- Cited by
- 1,185
- References
- 133
- FWCI
- 53.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.